ICON Development Solutions is a leading provider of outsourced regulatory
support to the pharmaceutical, biopharmaceutical and medical device
industries. With offices in the UK and US, and additional staff based
elsewhere in the EU, we can deliver global, regional or local scale
projects.
Apply our expertise in product development strategy and planning,
we offer:
Advice on:
Global regulatory requirements
Regulatory strategy
Interaction with regulatory agencies
Including EMEA, EU national agencies, FDA and other international agencies
Representation of clients or participation at regulatory agency meetings
Preparation of submission components and scientific documents including clinical,
non-clinical and quality summaries and overviews.
Publishing, both paper and electronic
Submissions management
Review and evaluation of regulatory data e.g. due diligence
PIL user testing
Whether as part of an overall programme management or provided on a standalone basis, we can help
with the full range of regulatory projects including clinical trail applications (CTA), investigational
new drug applications (IND), drug master files (DMF), pre-meeting briefing packages, marketing
applications (e.g. CTD, MAA, BLA, NDA), orphan product designations, responses to agency questions
and appeals, life cycle management and maintenance (e.g. annual reports, periodic safety updates,
variations, renewals).
We have one of the largest, longest established and most experienced contract regulatory groups with
extensive experience from previous senior roles within a variety of multinational pharmaceutical
companies. All of our consultants have a minimum of 5 years experience, and many have considerably
more. This experience, our proven track record of success and ISO quality certification makes ICON
Development Solutions a preferred partner for many of our clients, as proven by our 85% repeat
business.